Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-09

FDA Approved: COSOPT PF — Supplemental Application (Thea Pharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for COSOPT PF (dorzolamide hydrochloride and timolol maleate) by Thea Pharma Inc., marking an additional endorsement…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COSOPT PF (DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE)

Snippet

SUPPL AP for COSOPT PF (DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE)